Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Faucher

Showing results (131-140 of 149) with videos related to

Pageof 15
Sort By:
Bone Marrow Transplantation|May 11, 2004
Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantationM Mohty, J M Boiron, G Damaj, et al.
International Journal of Oncology|July 31, 1999
Production of ex vivo expanded hematopoietic cells and progenitors in a closed bioreactor, starting with a small volume marrow collection: A feasibility study in patients with poor-risk breast cancer and receiving high-doses of cyclophosphamideC Chabannon, J L Blache, I Sielleur, et al.
Bone Marrow Transplantation|December 13, 2016
Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation for high-risk AMLF Legrand, A-C Le Floch, A Granata, et al.
Bone Marrow Transplantation|November 10, 2015
T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromesR Devillier, S Bramanti, S Fürst, et al.
Leukemia|August 22, 2003
Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimenM Mohty, W Jacot, C Faucher, et al.
Leukemia|April 12, 2003
Cost-effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantationC Chabannon, A-G Le Corroller, F Viret, et al.
Bone Marrow Transplantation|March 3, 2016
Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamideL Castagna, S Bramanti, S Furst, et al.
Journal of Hematotherapy|December 1, 1996
Autologous transplantation of blood stem cells mobilized with filgrastim alone in 93 patients with malignancies: the number of CD34+ cells reinfused is the only factor predicting both granulocyte and platelet recoveryC Faucher, A G Le Corroller, C Chabannon, et al.
La Revue De Medecine Interne|January 14, 2024
French protocol for the diagnosis and management of hematopoietic stem cell transplantation in autoimmune diseasesD Farge, G Pugnet, M Allez, et al.
Bone Marrow Transplantation|November 24, 2015
Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamideL Castagna, S Bramanti, S Furst, et al.
Pageof 15

Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Bone Marrow Transplantation|May 11, 2004
Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantationM Mohty, J M Boiron, G Damaj, et al.
International Journal of Oncology|July 31, 1999
Production of ex vivo expanded hematopoietic cells and progenitors in a closed bioreactor, starting with a small volume marrow collection: A feasibility study in patients with poor-risk breast cancer and receiving high-doses of cyclophosphamideC Chabannon, J L Blache, I Sielleur, et al.
Bone Marrow Transplantation|December 13, 2016
Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation for high-risk AMLF Legrand, A-C Le Floch, A Granata, et al.
Bone Marrow Transplantation|November 10, 2015
T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromesR Devillier, S Bramanti, S Fürst, et al.
Leukemia|August 22, 2003
Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimenM Mohty, W Jacot, C Faucher, et al.
Leukemia|April 12, 2003
Cost-effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantationC Chabannon, A-G Le Corroller, F Viret, et al.
Bone Marrow Transplantation|March 3, 2016
Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamideL Castagna, S Bramanti, S Furst, et al.
Journal of Hematotherapy|December 1, 1996
Autologous transplantation of blood stem cells mobilized with filgrastim alone in 93 patients with malignancies: the number of CD34+ cells reinfused is the only factor predicting both granulocyte and platelet recoveryC Faucher, A G Le Corroller, C Chabannon, et al.
La Revue De Medecine Interne|January 14, 2024
French protocol for the diagnosis and management of hematopoietic stem cell transplantation in autoimmune diseasesD Farge, G Pugnet, M Allez, et al.
Bone Marrow Transplantation|November 24, 2015
Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamideL Castagna, S Bramanti, S Furst, et al.
Pageof 15